Novo Holdings A/S

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 3,650,737 shares
Security Ownership %: 6.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Novo Holdings A/S ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

17 Feb 2026 - Novo Holdings A/S has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,650,737 shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 6.4% ownership of the company. In their previous filing dated 20 Oct 2025, Novo Holdings A/S had reported owning 3,175,000 shares, indicating an increase of +15%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Novo Holdings A/S	6.4%	-5.7%	$28,694,793	3,650,737	+475,737	+15%	$7.86	13G/A	31 Dec 2025	17 Feb 2026, 18:55
Novo Holdings A/S	6.8%		$27,590,750	3,175,000			$8.69	13G	13 Oct 2025	20 Oct 2025, 17:12

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.1%	+0.96%	$27,380,528	3,650,737	+1,650,737	+83%	$7.50	Q4 2025
30 Sep 2025	1.1%	0%	$17,380,000	2,000,000	0		$8.69	Q3 2025
30 Jun 2025	0.52%	+0.01%	$7,420,000	2,000,000	+50,000	+2.6%	$3.71	Q2 2025
31 Mar 2025	0.48%	+0.11%	$6,298,500	1,950,000	+450,000		$3.23	Q1 2025
31 Dec 2024	0.51%	0%	$8,355,000	1,500,000	0		$5.57	Q4 2024
30 Sep 2024	0.81%	+0.05%	$16,215,000	1,500,000	+100,000	+7.1%	$10.81	Q3 2024
30 Jun 2024	1.6%	0%	$29,386,000	1,400,000	0		$20.99	Q2 2024
31 Mar 2024	3.3%	-0.24%	$44,604,000	1,400,000	-100,000	-6.7%	$31.86	Q1 2024
31 Dec 2023	2%	+0.41%	$30,390,000	1,500,000	+300,000	+25%	$20.26	Q4 2023
30 Sep 2023	1.1%	+0.19%	$15,276,000	1,200,000	+200,000	+20%	$12.73	Q3 2023
30 Jun 2023	1.4%	+0.42%	$18,070,000	1,000,000	+300,000	+43%	$18.07	Q2 2023
31 Mar 2023	0.86%	+0.86%	$12,033,000	700,000	+700,000	NEW	$17.19	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.